Alnylam Pharmaceuticals
Price & Volume
Stats
See moreOpen | $233.99 |
Previous Close | $232.68 |
Day Range | $226.75-$233.99 |
52W Range | $197.81-$495.55 |
Market Cap | $31.1B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $4.8B |
Revenue Growth (YoY) | 66.9% |
Gross Profit (12 Mos) | $3.8B |
Diluted EPS | $5.93 |
News
See moreYahoo Finance • 11 days ago
US Stock Market Today: S&P 500 Futures Steady As Traders Weigh Global Factory Strength
Yahoo Finance • 13 days ago
AMVUTTRA® (vutrisiran) ‘Play by Play’ Initiative Highlights Former Athletes’ Stories to Shine a Light on the Often-Missed Signs of ATTR-CM
Yahoo Finance • 21 days ago
4 Alzheimer's Drug Stocks to Watch on World Alzheimer's Day
Yahoo Finance • 27 days ago
Slate Medicines Names Kenneth Koblan as Chief Scientific Officer
About
CEO | Dr. Yvonne L. Greenstreet M.B.A., M.D. |
CFO | Mr. Jeffrey V. Poulton M.B.A. |
Address | 675 West Kendall Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2,500 |